What does it do? The term “oligosaccharide” refers
to a short chain of sugar molecules (“oligo” means “few” and
“saccharide” means “sugar.”) Fructo-oligosaccharides (FOS) and inulin,
which are found in many vegetables, consist of
short chains of fructose molecules. Galacto-oligosaccharides (GOS), which also occur
naturally, consist of short chains of galactose molecules. These compounds can be only
partially digested by humans.1 2 3 4 When
oligosaccharides are consumed, the undigested portion serves as food for
“friendly” bacteria, such as
Bifidobacteria and Lactobacillus species. Clinical studies have shown that
administering FOS, GOS, or inulin can increase the number of these friendly bacteria in the
colon while simultaneously reducing the population of harmful bacteria.5
6 7 8 9 Other benefits noted with FOS, GOS, or inulin
supplementation include increased production of beneficial short-chain fatty acids such as
butyrate, increased absorption of calcium and magnesium, and improved elimination of toxic
compounds.10 11
Because FOS, GOS, and inulin improve colon function and increase the number of friendly
bacteria, one might expect these compounds would help relieve the symptoms of irritable bowel syndrome. However, a double-blind trial
found no clear benefit with FOS supplementation (2 grams three times daily) in patients with
this condition.12 Experimental studies with FOS in animals suggest a possible
benefit in lowering blood sugar levels in people with
diabetes and in reducing elevated blood
cholesterol and triglyceride
levels.13
In a double-blind trial of middle-aged men and women with elevated cholesterol and
triglyceride levels, supplementation with inulin (10 grams per day for eight weeks)
significantly reduced insulin concentrations (suggesting an
improvement in blood-glucose control) and significantly lowered triglyceride
levels.14 In a preliminary trial, administration of FOS (8 grams per day for two
weeks) significantly lowered fasting blood-sugar levels and serum total-cholesterol levels in
patients with type 2 (non-insulin-dependent) diabetes.15 However, in another trial,
people with type 2 diabetes supplementing with FOS (15 grams per day) for 20 days found no
effect on blood-glucose or lipid levels.16 In addition, double-blind trials of
healthy people showed that supplementing with FOS or GOS for eight weeks had no effect on
blood-sugar levels, insulin secretion, or blood lipids.17 18 Because of
these conflicting results, more research is needed to determine the effect of FOS and inulin
on diabetes and lipid levels.
Several double-blind trials have looked at the ability of FOS or inulin to lower blood
cholesterol and triglyceride levels. These trials have shown that in people with elevated
total cholesterol or triglyceride levels, including people with type 2 diabetes, FOS or inulin (in amounts ranging from 8 to 20
grams daily) produced significant reductions in triglyceride levels. However, the effect on
cholesterol levels was inconsistent.19 20 21 22 In
people with normal or low cholesterol or triglyceride levels, FOS or inulin produced little
effect.23 24 25
References:
1. Molis C, Flourie B, Ouarne F, et al. Digestion, excretion, and energy
value of fructooligosaccharides in healthy humans. Am J Clin Nutr
1996;64:324–8.
2. van Dokkum W, Wezendonk B, Srikumar TS, van den Heuvel EG. Effect of
nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and
glucose absorption in young healthy male subjects. Eur J Clin Nutr
1999;53:1–7.
3. Alles MS, Hautvast JGA, Nagengast FM, et al. Fate of
fructo-oligosaccharides in the human intestine. Br J Nutr 1996;76:211–21.
4. Roberfroid M. Dietary fibre, inulin and oligofructose. A review
comparing their physiological effects. Crit Rev Food Sci Nutr 1993;33:103–48
[review].
5. Gibson GR, Beaty ER, Cummings JH. Selective stimulation of
bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology
1995;108:975–82.
6. Bouhnik Y, Flourie B, D’Agay-Abensour L, et al. Administration
of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic
fermentation metabolism in healthy humans. J Nutr 1997;127:444–8.
7. Bhounik Y, Vahedi K, Achour L, et al. Short-chain
fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in
healthy humans. J Nutr 1999;129:113–6.
8. Roberfroid MB, Van Loo JAE, Gibson GR. The bifidogenic nature of
chicory inulin and its hydrolysis products. J Nutr 1998;128:11–9.
9. Roberfroid M. Dietary fibre, inulin and oligofructose. A review
comparing their physiological effects. Crit Rev Food Sci Nutr 1993;33:103–48
[review].
10. Tomomatsu H. Health effects of oligosaccharides. Food
Technology 1994;October:61–5 [review].
11. van den Heuvel EG, Muys T, van Dokkum W, Schaafsma G. Oligofructose
stimulates calcium absorption in adolescents. Am J Clin Nutr 1999;69:544–8.
12. Hunter JO, Tuffnell Q, Lee AJ. Controlled trial of oligofructose in
the management of irritable bowel syndrome. J Nutr 1999;129:1451S–3S.
13. Delzenne NM. The hypolipidaemic effect of inulin: when animal studies
help to approach the human problem. Br J Nutr 1999;82:3–4 [review].
14. Jackson KG, Taylor GRJ, Clohessy AM, Williams CM. The effect of the
daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men
and women. Br J Nutr 1999;82:23–30.
15. Yamashita K, Kawai K, Itakura M. Effect of fructo-oligosaccharides on
blood glucose and serum lipids in diabetic subjects. Nutr Res 1984;4:961–6.
16. Roberfroid M. Dietary fibre, inulin and oligofructose. A review
comparing their physiological effects. Crit Rev Food Sci Nutr 1993;33:103–48
[review].
17. van Dokkum W, Wezendonk B, Srikumar TS, van den Heuvel EG. Effect of
nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and
glucose absorption in young healthy male subjects. Eur J Clin Nutr
1999;53:1–7.
18. Luo J, Rizkalla SW, Alamowitch C, et al. Chronic consumption of
short-chain fructooligosaccharides by health subjects decreased basal hepatic glucose
production but had no effect on insulin-stimulated glucose metabolism. Am J Clin Nutr
1996;63:939–45.
19. Yamashita K, Kawai K, Itakura M. Effect of fructo-oligosaccharides on
blood glucose and serum lipids in diabetic subjects. Nutr Res 1984;4:961–6.
20. Jackson KG, Taylor GRJ, Clohessy AM, Wlliams CM. The effect of the
daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men
and women. Br J Nutr 1999;82:23–30.
21. Roberfroid M. Dietary fibre, inulin and oligofructose. A review
comparing their physiological effects. Crit Rev Food Sci Nutr 1993;33:103–48
[review].
22. Davidson MH, Synecki C, Maki KC, Drennen KB. Effects of dietary
inulin in serum lipids in men and women with hypercholesterolaemia. Nutr Res
1998;3:503–17.
23. Luo J, Rizkalla SW, Alamowitch C, et al. Chronic consumption of
short-chain fructooligosaccharides by health subjects decreased basal hepatic glucose
production but had no effect on insulin-stimulated glucose metabolism. Am J Clin Nutr
1996;63:939–45.
24. Pedersen A, Sandstrom B, van Amelsvoort JMM. The effect of ingestion
of inulin on blood lipids and gastrointestinal symptoms in healthy females. Br J Nutr
1997;78:215–22.
25. van Dokkum W, Wezendonk B, Srikumar TS, van den Heuvel. Effect of
nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and
glucose absorption in young healthy male subjects. Eur J Clin Nutr
1999;53:1–7.
26. Duke JA. Handbook of phytochemical constituents of GRAS herbs and
other economic plants. Boca Raton, FL: CRC Press, 1992.
27. Carabin IG, Flamm WG. Evaluation of safety of inulin and
oligofructose as dietary fiber. Regul Toxicol Pharmacol 1999;30:268–82
[review].
28. Coussement PA. Inulin and oligofructose: safe intakes and legal
status. J Nutr 1999;129:1412S-7S [review].
29. Gay-Crosier F, Schreiber G, Hauser C. Anaphylaxis from inulin in
vegetables and processed food. N Engl J Med 2000;342:1372 [letter].